nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cell Proliferation, Apoptosis, and Expression of Bcl-2 and Bax in Non-Lactating Human Breast Epithelium in Relation to the Menstrual Cycle and Reproductive History
|
F. Feuerhake |
|
2003 |
77 |
1 |
p. 37-48 12 p. |
artikel |
2 |
Cell Proliferation, Apoptosis, and Expression of Bcl-2 and Bax in Non-Lactating Human Breast Epithelium in Relation to the Menstrual Cycle and Reproductive History
|
Feuerhake, F. |
|
2003 |
77 |
1 |
p. 37-48 |
artikel |
3 |
Development and Characterization of a Progressive Series of Mammary Adenocarcinoma Cell Lines Derived from the C3(1)/SV40 Large T-antigen Transgenic Mouse Model
|
Ryan G. Holzer |
|
2003 |
77 |
1 |
p. 65-76 12 p. |
artikel |
4 |
Development and Characterization of a Progressive Series of Mammary Adenocarcinoma Cell Lines Derived from the C3(1)/SV40 Large T-antigen Transgenic Mouse Model
|
Holzer, Ryan G. |
|
2003 |
77 |
1 |
p. 65-76 |
artikel |
5 |
Evaluation of Lymph Node Status in Male Breast Cancer Patients: A Role for Sentinel Lymph Node Biopsy
|
Daniel Albo |
|
2003 |
77 |
1 |
p. 9-14 6 p. |
artikel |
6 |
Evaluation of Lymph Node Status in Male Breast Cancer Patients: A Role for Sentinel Lymph Node Biopsy*
|
Albo, Daniel |
|
2003 |
77 |
1 |
p. 9-14 |
artikel |
7 |
Matrix Metalloproteinase-2 (MMP-2) in T12N0 breast carcinoma
|
Riikka Hirvonen |
|
2003 |
77 |
1 |
p. 85-91 7 p. |
artikel |
8 |
Matrix Metalloproteinase-2 (MMP-2) in T1–2N0 breast carcinoma
|
Hirvonen, Riikka |
|
2003 |
77 |
1 |
p. 85-91 |
artikel |
9 |
Polymorphisms in Steroid Hormone Pathway Genes and Mammographic Density
|
Christopher A. Haiman |
|
2003 |
77 |
1 |
p. 27-36 10 p. |
artikel |
10 |
Polymorphisms in Steroid Hormone Pathway Genes and Mammographic Density
|
Haiman, Christopher A. |
|
2003 |
77 |
1 |
p. 27-36 |
artikel |
11 |
Sequential Doxorubicin and Docetaxel as First-Line Treatment in Metastatic Breast Cancer: A GEICAM-9801 Phase II Study
|
E. Alba |
|
2003 |
77 |
1 |
p. 1-8 8 p. |
artikel |
12 |
Sequential Doxorubicin and Docetaxel as First-Line Treatment in Metastatic Breast Cancer: A GEICAM-9801 Phase II Study
|
Alba, E. |
|
2003 |
77 |
1 |
p. 1-8 |
artikel |
13 |
Sex Hormone-Induced Mammary Carcinogenesis in Female Noble Rats: Detection of Differentially Expressed Genes
|
G. Leung |
|
2003 |
77 |
1 |
p. 49-63 15 p. |
artikel |
14 |
Sex Hormone-Induced Mammary Carcinogenesis in Female Noble Rats: Detection of Differentially Expressed Genes
|
Leung, G. |
|
2003 |
77 |
1 |
p. 49-63 |
artikel |
15 |
The Expression of Growth Hormone-Releasing Hormone (GHRH) and its Receptor Splice Variants in Human Breast Cancer Lines; The Evaluation of Signaling Mechanisms in the Stimulation of Cell Proliferation
|
M. Olga Garcia-Fernandez |
|
2003 |
77 |
1 |
p. 15-26 12 p. |
artikel |
16 |
The Expression of Growth Hormone-Releasing Hormone (GHRH) and its Receptor Splice Variants in Human Breast Cancer Lines; The Evaluation of Signaling Mechanisms in the Stimulation of Cell Proliferation
|
Garcia-Fernandez, M. Olga |
|
2003 |
77 |
1 |
p. 15-26 |
artikel |
17 |
The Prognostic Value of the Mitotic Activity Index in Patients with Primary Breast Cancer Who were not Treated with Adjuvant Systemic Therapy
|
P. Manders |
|
2003 |
77 |
1 |
p. 77-84 8 p. |
artikel |
18 |
The Prognostic Value of the Mitotic Activity Index in Patients with Primary Breast Cancer Who were not Treated with Adjuvant Systemic Therapy
|
Manders, P. |
|
2003 |
77 |
1 |
p. 77-84 |
artikel |